I am a hematologist-oncologist specializing in the care of patients with lymphoma. My goal is to provide the best possible care for these patients, and to discover new and scientifically grounded treatments that can improve management and increase the cure rate of lymphoma., As an oncologist, I am committed to combining compassionate and personalized patient care with cutting-edge, patient-focused, and translational research. I strive to develop a treatment plan for each patient that is designed to fit the persons unique situation, as well as the biology of his or her tumor. At NYU Langones Perlmutter Cancer Center, our team of experts from various specialties provides outstanding and compassionate clinical care to people with all types of lymphoma. We have the advantage of being at the forefront of advanced research, coupling personalized care with some of the most innovative and groundbreaking clinical trials in the nation. We provide people with access to many exciting new treatments before they are commercially available.I am currently leading a national clinical trial for patients with relapsed Hodgkin lymphoma. I also serve as the principal investigator for numerous clinical trials at NYU Langone involving a range of different therapies, including targeted therapy, immunotherapy, and radiation therapy. Many of these clinical trials explore innovative methods of combining new targeted or immune-based therapies with existing therapies to find new ways to control lymphoma,